Perioperative Management of Antiplatelet Therapy in Patients With History of Coronary Artery Disease Undergoing Surgery for Esophageal Cancer: A Single-center Experience
- Resource Type
- Authors
- Dimitrios Schizas; Damianos G. Kokkinidis; Vasileia Domi; Nikoletta A Theochari; Anargyros Bakopoulos; Anil Kumar Jonnalagadda; Theodore Liakakos; Alkistis Kapelouzou; Eustratia Mpaili; Christina A. Theochari
- Source
- In Vivo. 33:621-626
- Subject
- Male
Cancer Research
medicine.medical_specialty
Ticlopidine
Esophageal Neoplasms
medicine.medical_treatment
Population
Hemorrhage
Coronary Artery Disease
Single Center
Risk Assessment
Perioperative Care
General Biochemistry, Genetics and Molecular Biology
Coronary artery disease
03 medical and health sciences
0302 clinical medicine
Risk Factors
Humans
Medicine
Myocardial infarction
education
Stroke
Aged
Pharmacology
education.field_of_study
business.industry
Middle Aged
Esophageal cancer
medicine.disease
Clopidogrel
Surgery
Esophagectomy
030220 oncology & carcinogenesis
Concomitant
Female
Stents
business
Platelet Aggregation Inhibitors
Research Article
- Language
- ISSN
- 1791-7549
0258-851X
Aim: To present the experience of the upper Gastrointestinal Unit of the Surgical Department of National and Kapodistrian University of Athens in order to inform surgeons of the exact harms and benefits associated with their decisions concerning management of antiplatelet therapy. Materials and Methods: This was a single-center study of patients who underwent surgery for esophageal cancer and had concomitant coronary artery disease from 1/1/2005 to 31/7/2017. Patients were divided into two cohorts based on when their antiplatelet therapy was stopped (